Dr Reddy's
Mar 19, 2024
Chennai, March 19 (IANS) Pharma major Dr Reddy's Laboratories Ltd on Tuesday announced the launch of its cancer drug Versavo (bevacizumab) in the UK.
Jan 31, 2024
Larsen & Toubro: Recorded a 15 percent year-on-year growth in consolidated net profit at Rs 2,947 crore during Q3. EBITDA margin dropped by 50 basis points to 10.4 percent for the quarter.
Oct 11, 2022
HYDERABAD: Global pharmaceutical company Dr.
Feb 02, 2022
Hyderabad: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, NSEIFSC: DR REDDY, hereafter referred to as “Dr. Reddy’s”) announces two major back-to-back recognitions in...
May 18, 2021
Drug firm Shilpa Medicare and Dr Reddy's Laboratories entered into an agreement under which they will together be manufacturing the Sputnik V vaccine.
Sep 16, 2020
MOSCOW/HYDERABAD: The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr Reddy’s Laboratories Ltd, a global pharmaceutical company headquartered out of India, have agreed...
Feb 12, 2020
Dr Reddy’s Laboratories Ltd entered into a definitive agreement with Wockhardt Ltd to acquire select divisions of its branded generics business in India
Jul 31, 2019
Dr Reddy’s Laboratories was expecting an inspection of its Active Pharmaceuticals Ingredients (API) plant at Srikakulam in Andhra Pradesh
Jul 26, 2016
The scholarship programme aims to ensure that students do not discontinue their studies due to lack of financial resources.
